(and dosage form):
Contains per mL:
|| 5 mg|
Phenylmercuric acetate 0,002% m/v
A. 15.4 Ophthalmic preparations. Other.
Tetracaine is a topical anaesthetic and is considerably more powerful than procaine or cocaine and tetracaine shows regularity in depth and duration of anaesthesia. It has minimal drying effects upon epithelium and does not dilate the pupil or disturb accommodation.
For topical anaesthesia of the eye prior to tonometry or foreign body removal.
Covostet should not be used on surfaces that are or will be extensively traumatised. Use with caution in allergic subjects particularly in patients allergic to topical anaesthetics of the caine series.
Do not use Covostet with mercury or silver salts. Do not use more than 30 days after opening.
DOSAGE AND DIRECTIONS FOR USE:
Apply one or two drops to the conjunctiva.
Not to be used while wearing contact lenses.
SIDE-EFFECTS AND SPECIAL PRECAUTIONS:
Covostet occasionally causes smarting in the eye. On rare occasions lacrimation, photophobia, and chemosis in sensitive patients may be produced. Covostet may increase intra-ocular pressure and cause cardio-vascular collapse.
Local anaesthetics, can be used with safety in nearly all patients if suitable precautions are observed. They should be applied more sparingly on open lesions and in patients with allergy, cardiac and hepatic disease, emaciation, hyperthyroidism, and other endocrine disorders in which tolerance may be diminished. Long continued application of Covostet solution is not recommended.
15 mL in an opaque dropper bottle with dropper insert and yellow cap.
Store below 25°C. Keep tightly closed and protect from light.
Do not use more than 30 days after opening.
KEEP OUT OF REACH OF CHILDREN
NAME AND BUSINESS ADDRESS OF THE APPLICANT:
ADCOCK INGRAM LIMITED
Adcock Ingram Park
17 Harrison Avenue
P/Bag X 69
DATE OF PUBLICATION OF THIS PACKAGE INSERT:
18 January 1974
New addition to this site: April 2004
Source: Pharmaceutical Industry
SAEPI HOME PAGE
TRADE NAME INDEX
GENERIC NAME INDEX
Information presented by Malahyde Information Systems © Copyright 1996-2004